Financial Information

Capital Market Release


PTA-News: Dr. Hönle AG: Hönle Group increases sales by 12% in 9 months

05.08.2022

Gilching (pta009/05.08.2022/08:00) - Sales revenues generated by the Hönle Group rose by 12% to T€ 95,141 in the first nine months of financial year 2021/2022 compared with the prior-year period.

read more ...

 

PTA-News: Dr. Hönle AG: Restructuring of the Management Board of Dr. Hönle AG

16.05.2022

Gilching (pta026/16.05.2022/11:45) - The supervisory board of Dr. Hönle AG has decided to restructure the Management Board of Dr. Hönle AG.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle increases its operating result by 14% to € 7.7 million in six months

12.05.2022

Gilching (pta006/12.05.2022/08:00) - The economic recovery impacted positively on the Hönle Group's course of business. Both incoming orders and order backlog were clearly above the prior year's level. An even higher rise in revenue failed to realise due to long delivery times concerning...

read more ...

 

Adhoc Release


PTA-Adhoc: Dr. Hönle AG: Hönle achieves an operating result of € 7.2 million in the 9-month period

29.07.2022

Gilching (pta042/29.07.2022/14:20) - Earnings in the third quarter were worse than planned. The situation on procurement markets and the increase in energy prices burden on quarterly earnings heavily. In addition, one-time effects affected the result. These are largely related to the...

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG adjusts outlook for 2021/2022 financial year

22.07.2022

Gilching (pta028/22.07.2022/14:55) - Business development in the third quarter and especially in June 2022 was significantly worse than planned. The situation on procurement markets and the sharp increase in energy prices temporarily burden heavily on the Hönle Group's earnings. In...

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG puts annual forecast into concrete terms

18.02.2022

Gilching (pta012/18.02.2022/09:40) - The Management Board expects revenues of between € 130 and € 140 for the Hoenle Group and an operating result (EBIT) of between € 14 and € 17 million in financial year 2021/2022.

read more ...

 

Find more Articles in our archives.

» Archives

 


 

Facts & Figures

Sales Revenues Hönle Group: till 98/99: "as-if"-accounts
EBIT Hönle Group: till 98/99: "as-if"-account, since 04/05: "share-based" payment according to IFRS2
Net Profit Hönle Group: till 98/99: "as-if"-accounts before results shares of that atypical allay shareholder, since 04/04: "share-based" payment according IFRS2
Number of Employees in the Hönle Group:  data at the end of fiscal year, without board of directors


 

7 Good Reasons

  1. Leading Market Position
  2. Expansion in Existing Markets
  3. Technological Lead
  4. Hönle as a Process Accelerator
  5. Expansion in Growth Markets
  6. Internationalization
  7. Strong Partners
show more

1. Leading Market Position

Dr. Hönle AG is among the global leaders in the area of UV technology for industrial applications. We are a pace setter in UV technology and in the development of new applications. Our clientele stands for competence and innovation capability. Our customers include leading companies from all target industries. Manroland, Durst, Q.Cells, Philips and Tetra Pak are working with Hönle UV systems.


2. Expansion in Existing Markets

We utilize the benefits of industrial UV technology in the optimization of many production processes in the most diverse of industries. Thus, for example the use of UV-reactive colours yields significant time savings and the production of first-class end products. The 100% solvent-free paints and varnishes do not pose any hazards to humans and the environment. This is why traditional production processes are increasingly being replaced by UV-reactive methods.


3. Technological Lead

The number of UV applications is rapidly expanding and the technology is entering an increasing field of applications. Hönle has launched a completely new device for DVD production. We not only continue to develop established technologies but are also setting standards for tapping new application fields in close cooperation with other companies, universities and research institutes.


4. Hönle as a Process Accelerator

The use of UV systems can simplify production processes, raise productivity and enable direct further processing. This simplifies just in time deliveries and thus provides our customers with an important competitive advantage.


5. Expansion in Growth Markets

Digital Printing and adhesives for industrial applications are areas in which our UV technology plays an increasingly important role. We will continue to intensify our activities in these fields. The price competition has intensified in many of the growth markets. This increasingly puts us under significant pressures to increase productivity and quality. The use of UV technology contributes to productivity increases in numerous production processes and facilitates more precise production steps.


6. Internationalization

Hönle has an international distribution network, which gives us a worldwide presence in close proximity to our customers. In particular, the strong European position provides us with a solid foundation for our continued dynamic internationalization, primarily in the USA and South-East Asia. The export content is over 50%.


7. Strong Partners

Development partnerships with leading companies, such as in the printing industry, the production of CD’s and DVD’s and mobile phone production form the foundation for our technological lead. Among others we cooperate with Manroland, Mark Andy and Philips. With the development of new methods we ensure our development leadership and mutually benefit from the exchange of experience.


 

show less


Disclaimer

The articles and analyses published on our web pages are intended only for informational purposes and do not represent offers for the purchase or selling of securities or other investment instruments. The present data are compiled to the best of our knowledge and in good faith. With regard to future-related statements neither Dr. Hönle AG nor any of the associated companies can assume responsibility for the occurrence of the forecast. Due to changing general economic conditions or other factors beyond the control of Dr. Hönle AG, future results may differ considerably from the forecast. Irrespective of legal obligations for adjusting forecasts, Dr. Hönle AG does not intend to continually update all statements related to the future.